what is known already: Oscillations in cytoplasmic calcium concentration are crucial for oocyte activation and further embryonic development. While several studies have described in detail the calcium oscillation pattern during fertilization in animal models, studies with human oocytes are scarce. study design, size, duration: This was a laboratory-based study using human MII oocytes matured in vivo or in vitro either fresh or after cryopreservation with slow freezing or vitrification. Altogether, 205 human oocytes were included in the analysis.
Introduction
Calcium is an indispensable signal for normal mammalian fertilization. The oocyte, arrested at the metaphase of the second meiotic division (MII), is activated by the fertilizing sperm to complete meiosis and begin embryonic development (Stricker, 1999) . Following the fusion of the sperm and oocyte membranes, the sperm triggers a prolonged series of low-frequency oscillations in cytoplasmic calcium concentration between meiosis resumption and entry into interphase of the first embryonic cell cycle (Miyazaki et al., 1993; Stricker, 1999) .
The initiation of calcium oscillations is thought to be triggered by the sperm factor phospholipase C zeta (PLCz), which is released into the oocyte following gamete fusion Saunders et al., 2002; Yoon et al., 2008; Kashir et al., 2010; Nomikos et al., 2012) . PLCz hydrolyzes internal stores of phosphatidylinositol 4,5-bisphosphate into diacylglycerol and inositol 1,4,5-trisphosphate (IP 3 ), which activates the IP 3 receptor type 1 (IP 3 R1) located on the membrane of the endoplasmic reticulum (ER) leading to the cytoplasmic release of calcium (Miyazaki et al., 1993; Xu et al., 1994; Yu et al., 2012) . Through a complex series of nuclear and cytoplasmic events from the germinal vesicle (GV) to the MII stage, collectively referred to as oocyte maturation, the oocyte gradually acquires the aforementioned ability to exhibit calcium oscillations at fertilization and thereby to initiate embryonic development (Mehlmann and Kline, 1994; Jones et al., 1995) .
The spatio-temporal information of the calcium oscillations, such as the amplitude, duration and frequency, is decoded by downstream effectors that mediate oocyte activation and affects important aspects of preand post-implantation embryonic development (Kline and Kline, 1992; Tombes et al., 1992; Jones et al., 1995; Bos-Mikich et al., 1997; Ozil and Huneau, 2001; Ozil et al., 2006; Tó th et al., 2006) . In the absence of appropriate calcium signalling at fertilization the embryo may fail to implant and/or develop to full term (Ducibella et al., 2006) . Cell cycle resumption is promoted by the activity of calcium/calmodulin-dependent protein kinase II gamma (CaMKIIg), which oscillates in synchrony with the calcium oscillations, leading to the degradation of cyclin B and the decrease of the maturation promoting factor and mitogen-activated protein kinase (Ducibella et al., 2006; Backs et al., 2010) .
The frequency and duration of calcium oscillations vary between species (Stricker, 1999) . The first calcium transient in mouse oocytes occurs about 1 min after the fusion of sperm and oocyte plasma membranes and lasts for one to several minutes before returning to baseline (Cuthbertson and Cobbold, 1985) . The subsequent calcium oscillations occur about every 10 min and continue for several hours (Kline and Kline, 1992) . Calcium influx in mouse oocytes is essential for sustaining the repetitive pattern of the calcium oscillations and for completing oocyte activation by replenishing the calcium stores (Miao et al., 2012) . While several studies have described in detail the calcium oscillation pattern during fertilization in mouse oocytes and other animal models, studies with human oocytes after IVF (Taylor et al., 1993; Sousa et al., 1996a; or ICSI are relatively scarce (Tesarik et al., 1994; Yanagida et al., 2001) . The limited number of human in vivo matured MII oocytes donated for research together with ethical concerns hinders extensive studies. Research has therefore been performed primarily with in vitro matured (Yanagida et al., 2001) or failed fertilized oocytes (Taylor et al., 1993; Tesarik et al., 1994; Sousa et al., 1996a) in addition to a few in vivo MII oocytes. The results obtained, however, were not always reported separately for the different oocyte groups (Taylor et al., 1993; Tesarik et al., 1994; Sousa et al., 1996a,b; Yanagida et al., 2001) .
In vitro matured oocytes obtained from stimulated cycles can be sometimes utilized for the patient's treatment cycle in cases with no or few recovered in vivo matured MII oocytes. However, fertilization and implantation rates are inferior compared with in vivo matured MII ( Vanhoutte et al., 2005; Escrich et al., 2011; Fasano et al., 2012; Shin et al., 2013) . Failed fertilization after IVF is mostly due to the sperm's inability to bind to or to penetrate the zona pellucida. Therefore, these oocytes usually do not contain sperm (Rawe et al., 2000; Mahutte and Arici, 2003) and have been subjected to rescue ICSI in the past with highly variable outcomes (Morton et al., 1997; Kuczyński et al., 2002) . In vitro matured and IVF failed fertilized oocytes are both occasionally utilized clinically in addition to providing a source of oocytes for research.
Cryopreservation of in vivo MII oocytes, especially by means of vitrification rather than slow freezing, has greatly enhanced the utilization of oocytes particularly in fertility preservation and donation programs (Wang et al., 2001; Smith et al., 2010; Lee et al., 2012) . Apart from being almost indispensable for clinical practice, cryopreservation may also provide a source of human oocytes for research. However, both slow freezing and vitrification can affect cellular functions and compromise normal embryonic development Kim et al., 2011) . Although more than 900 live births have resulted so far from oocyte cryopreservation (Noyes et al., 2009) , no study has addressed how cryopreservation affects calcium signalling during fertilization.
The aim of this study was to determine the precise pattern of calcium oscillations in human fertilized oocytes matured either in vivo or in vitro or aged in vitro, as well as to assess the effect of cryopreservation by vitrification and slow freezing. A better understanding of how these processes influence the normal pattern of calcium oscillations during fertilization could eventually lead to improvements in clinical assisted reproduction practices.
Methods

Reagents
All chemicals were purchased from Sigma-Aldrich (Diegem, Belgium) unless otherwise specified.
Ethical approval
The study was approved by the local ethical committee of Ghent University Hospital (2009/130) and by the Belgian Federal Ethical Committee (Adv020) and written informed consent was obtained from patients undergoing controlled ovarian hyperstimulation for ICSI and IVF treatment.
Source of human oocytes
Patients undergoing ICSI/IVF treatment at the Ghent University Hospital between October 2011 and December 2012 were included in this study. The baseline characteristics of the included patients are shown in Table I . Women were down-regulated with either a gonadotrophin-releasing hormone (GnRH) agonist (Decapeptyl; Ferring) or antagonist (Cetrotide; Merck Serono) protocol. Ovarian stimulation was performed with human menopausal gonadotrophin (hMG, Menopur; Ferring) or recombinant follicle stimulating hormone (recFSH, Gonal-F; Merck Serono) and ovulation was induced with 5000 IU human chorionic gonadotrophin (hCG, Pregnyl; MSD). Oocytes were enzymatically denuded by brief exposure to 80 IU ml hyaluronidase (Cook Medical), followed by mechanical denudation. The nuclear status was assessed and classified as GV, MI or MII stage. In vivo matured MII oocytes (in vivo MII) were donated in cases when no sperm was available for ICSI on the day of oocyte retrieval. In vivo MII oocytes that had not shown pronuclei formation or extrusion of the second polar body at fertilization check and by 24 h following IVF comprised the in vitro aged MII group. Donated oocytes that had failed to mature following controlled ovarian hyperstimulation and were either at the GV stage (defined by the presence of a GV structure) or MI stage (defined by the absence of both a polar body and a GV structure) were cultured in vitro. Immature oocytes from different patients were allocated randomly to the various experimental groups. Patients with .40% immature oocytes were excluded from the study.
In vitro maturation
Oocytes at the GV stage were cultured in medium 199 (M199) at 378C under 6% CO 2 , 5% O 2 and 89% N 2 . M199 was supplemented with 10 ng/ml epidermal growth factor, 1 mg/ml estradiol, 10 mIU/ml recFSH, 0.5 mIU/ml hCG, 1 mM l-glutamine, 0.3 mM sodium pyruvate, 0.8% (v/v) human serum albumin (HSA) (Red Cross, Belgium), 100 IU/ml penicillin G and 100 mg/ml streptomycin sulphate. Oocytes with a polar body extruded within 24 h (GV -MII 24 h) of culture were used for this study. Oocytes collected at the MI stage were cultured in Sydney IVF cleavage medium (CC) (Cook Ireland Ltd) at 378C under 6% CO 2 , 5% O 2 and 89% N 2 . Oocytes with a polar body extruded within 3 or 24 h of culture were used for this study (MI-MII 3 h and MI -MII 24 h, respectively).
Slow freezing and thawing
GV -MII 24 h, MI -MII 3 h, MI -MII 24 h and in vitro aged oocytes were cryopreserved using a two-step 1,2-propanediol-sucrose slow freezing/thawing (F/T) protocol. All solutions were prepared in Dulbecco's phosphatebuffered saline solution (DPBS) (Gibco) supplemented with 0.5% (v/v) HSA. Oocytes were first incubated in DPBS/0.75 M 1,2-propanediol and then transferred to DPBS/1.5 M 1,2-propanediol for 7.5 min at room temperature (RT). Oocytes were finally incubated in DPBS/1.5 M 1,2-propanediol/0.3 M sucrose for 5 min at RT during which time they were loaded into 0.25 ml plastic straws (Cryo Bio System) and placed in the freezing machine (Planer Kryo 10). The initial chamber temperature of 208C decreased to 288C at a rate of 28C/min before manual seeding was performed. After a holding period of 8 min, the temperature decreased to 2308C at a rate of 0.38C/min and then rapidly to 21508C at a rate of 508C/min. Ten minutes later the straws were plunged into liquid nitrogen and stored for later use. For thawing, straws were held in the air for 30 s and then at 378C for 40 s. Oocytes were sequentially incubated in DPBS/ 1 M 1,2-propanediol/0.3 M sucrose, DPBS/0.5 M 1,2-propanediol/0.3 M sucrose and DPBS/0.3 M sucrose (5 min at RT for each). Then, the oocytes were transferred into DPBS for 5 min at RT and 5 min at 378C. Afterwards they were cultured in CC medium at 378C under 6% CO 2 , 5% O 2 and 89% N 2 and evaluated 1.5 h later for morphological survival.
Vitrification and warming
In vivo MII, GV-MII 24 h, MI -MII 3 h, MI -MII 24 h and in vitro aged oocytes were vitrified/warmed (V/W) according to a closed vitrification protocol (Irvine Scientific). Vitrification and warming solutions were prepared in HEPES-buffered M199 supplemented with 20% dextran serum supplement. Oocytes were initially incubated in a 50 ml drop of Sydney IVF Gamete buffer medium (GB) (Cook Ireland Ltd) for 1 min at 378C and for 1 min at RT. The GB drop was then merged for 2 min with an adjacent 50 ml drop of equilibration solution (ES) containing 7.5% ethylene glycol and 7.5% DMSO. The resulting drop was further merged with a fresh drop of ES for 2 min before incubating the oocytes in a separate 50 ml ES drop for 10 min at RT. Then, oocytes were sequentially incubated at RT in 4 drops of 25 ml vitrification solution containing 15% (v/v) ethylene glycol, 15% (v/v) DMSO and 0.5 M sucrose for 60 -90 s in total. The oocytes were finally loaded onto High Security straws (Cryo Bio System) with a minimal volume and the straws were thermo sealed before being plunged into liquid nitrogen. For warming, oocytes were immediately placed in a 500 ml drop of thawing solution containing 1 M sucrose for 1 min at 378C and then for 1 min at RT. Oocytes were then placed in a 50 ml drop of thawing solution for 1 min at RT and then in two 50 ml drops of dilution solution containing 0.5 M sucrose for 2 min each. Finally, oocytes were incubated in three 50 ml drops of washing solution for 3 min each. Following the warming procedure, oocytes were cultured in CC medium at 378C under 6% CO 2 , 5% O 2 and 89% N 2 and evaluated 1.5 h later. 
ICSI and calcium oscillation pattern analysis
Morphologically normal MII human oocytes, either fresh or after the thawing or warming process, were loaded with 7.5 mM of the ratiometric calciumsensitive dye Fura-2 acetoxymethyl (AM) ester (Invitrogen) at 378C under 6% CO 2 , 5% O 2 and 89% N 2 for 30 min and then washed extensively. Frozen/thawed sperm from a single donor with proven oocyte activation capacity and fertility was used for all the experiments. After ICSI, oocytes were placed in a CC medium drop on a glass bottom dish (MatTek). Calcium imaging was performed on an inverted epifluorescence microscope (TH4-200, Olympus Soft Imaging Solutions GmBH, Belgium) with a 10× objective and began 10-15 min after the initiation of ICSI. Fluorescence measurements were made every 30 s for 16 h with a filter switch that provided excitation alternating between 340 and 380 nm and no illumination was applied between measurements. For a separate group of MI-MII 3 h oocytes data acquisition was performed every 2 s to obtain more complete definition of the first two calcium rises. The concentration of free intracellular calcium was proportional to the ratio of fluorescence at 340/380 (expressed in arbitrary units, AU). The microscope was equipped with an Okolabs stage micro-environmental chamber enclosed in a CO 2 microscope cage incubator so that all measurements were conducted at 378C under 6% CO 2 . Following calcium imaging, oocytes were evaluated and only those that survived were included for calcium oscillation pattern analysis. The number of oocytes surviving the process of ICSI and the number of oocytes that did subsequently show calcium responses during the calcium measurement period did not differ significantly between the groups (Table II) . The following calcium oscillation pattern parameters were calculated for each oocyte: latency (time in minutes from initiation of the calcium measurement to the start of the first calcium transient), duration of each transient (time in minutes from the start of the increase until return to baseline), amplitude (peak ratio of fluorescence at 340/380 subtracted from the baseline expressed in AU), frequency (number of calcium transients/h), the total duration of calcium oscillations (time of last calcium transient minus the latency expressed in h) and total calcium released (the sum of the area under the curve of all calcium peaks as determined by the trapezoidal method expressed in AU × min). Calcium transients with an amplitude ≤ 0.2 AU were excluded from the analysis of the calcium oscillation parameters. The number of oocytes per group that showed calcium transients was analysed is presented in Table II .
Statistical analysis
Median values and the interquartile range for latency, calcium transient duration, calcium transient amplitude, frequency and total duration were compared using the Mann -Whitney U-test (Prism 5.0, GraphPad). A P value ,0.05 was considered statistically significant. Significance among oocyte groups is denoted by different superscripts.
Results
The calcium oscillation pattern of human in vivo MII oocytes
In vivo MII human oocytes exhibited a characteristic pattern of calcium oscillations following ICSI (Fig. 1A) . This consisted of a series of sharp increases in calcium followed by a return to baseline. The first calcium transient [median (interquartile range)] appeared 42 (26 -94) min following the initiation of calcium imaging. It was the highest one with an amplitude of 1.1 (1-1.4) AU, as well as the longest one with a duration of 4 (3.5-4) min (Fig. 1A) . The subsequent calcium oscillations had a lower amplitude of 0.6 (0.6 -0.8) AU and each lasted for 2.5 (2.2 -2.8) min. Persistent calcium oscillations appeared with a frequency of 2.4 (2-3.8) calcium transients/h for a total period of 4.2 (3.4 -5) h and the total amount of calcium released was 5.1 (4.7 -7.0) AU × min (Table II) .
Effect of in vitro maturation and in vitro ageing
In vitro maturation of human oocytes, either from the GV or MI stage, altered the calcium oscillation pattern compared with in vivo MII oocytes, with calcium oscillations occurring at a significantly lower frequency and being of shorter duration (Fig. 1B-E ). More specifically, calcium oscillations occurred with a frequency of 1.7 (1.4 -2), 1.7 (1.3 -2.3) and 1.8 (1.4 -2.4) calcium transients/h in the GV -MII 24 h, MI -MII 3 h and MI -MII 24 h groups respectively (Table II) . The duration of the first calcium transient was 3 (2.5 -3.5), 3 (2 -3.5) and 3 (2.9 -3.5) min, while the subsequent calcium transients lasted for 1.8 (1.6 -2), 1.5 (1.4 -1.6) and 1.6 (1.5 -1.8) min in the GV -MII 24 h, MI-MII 3 h and MI -MII 24 h groups respectively. Calcium oscillations occurred for a significantly longer period of 7.5 (5.3 -10.1) hours in the MI-MII 3 h compared with the in vivo MII group (Fig. 1C) . The first calcium transients in MI -MII 3 h oocytes are shown on an expanded time-scale in Fig. 1D . When MI oocytes took 24 h to mature to the MII stage, the amplitude of the calcium transients was also affected, being 1.8 (1.5 -2.1) AU for the first one and 0.9 (0.7 -1.1) AU for the subsequent ones (Fig. 1E ).
Similarly to the in vitro matured oocytes, in vitro aged oocytes also showed calcium oscillations of lower frequency and shorter duration compared with in vivo MII oocytes (Fig. 1F) . Calcium transients occurred with a frequency of 1.5 (1.2 -2.1) calcium transients/h and the first lasted for 3 (2.5 -3.5) min while the subsequent ones for 1.5 (1.4 -1.8) min. Additionally, the amplitude of the first calcium transient in in vitro aged oocytes was of significantly higher amplitude of 2.3 (1.9 -2.5) AU as was the total duration period of the calcium oscillations, which was 8.1 (5-11.3) hours compared with in vivo MII oocytes. These differences are reflected also in the significantly higher amount of total calcium released in in vitro aged compared with in vivo MII oocytes, which was 9.8 (7.8 -14.0) AU × min.
The calcium oscillation pattern of vitrified/ warmed human in vivo MII oocytes
The process of vitrification/warming (V/W) altered the calcium oscillation pattern of in vivo MII oocytes compared with fresh ones (Fig. 2A) . Specifically, the amplitude of the calcium transients significantly increased to 1.7 (1.3 -2) AU and 0.9 (0.8 -1.2) AU for the first and the subsequent ones respectively (Table II) . The calcium oscillations occurred for a significantly longer time of 9.1 (5.4 -10.5) hours compared with in vivo MII oocytes, yet with a lower frequency of 1.2 (0.9 -1.4) calcium transients/h. Nevertheless, the area under the curve of all the calcium transients significantly increased to 8.5 (5.7 -13.3) AU × min.
The calcium oscillation pattern of vitrified/ warmed in vitro matured and in vitro aged human oocytes
Similarly to in vivo MII oocytes, in vitro matured oocytes also showed altered calcium oscillation parameters following V/W compared with their fresh counterparts (Fig. 2B-D) . As shown in Table II Calcium oscillations in human fertilized oocytes 24 h, the amplitude of the calcium oscillations exhibited by GV-MII 24 h V/W significantly increased to 1.8 (1.4 -2.2) AU for the first calcium transient and to 0.8 (0.7 -0.9) AU for the subsequent ones, while the frequency decreased to 1.3 (0.9 -1.6) calcium transients/h. The duration of the subsequent calcium transients also decreased to 1.6 (1.5-1.7) min compared with GV -MII 24 h, whereas the total calcium released increased to 8.4 (4.8-12.4) AU × min. The amplitude for MI -MII 3 h V/W versus MI -MII 3 h increased to 1.9 (1.3 -2) AU for the first transient and to 1.2 (1 -1.4) AU for the subsequent ones, while the frequency decreased to 1.2 (0.9-1.6) calcium transients/h. Moreover, the duration of the first calcium transient decreased to 2 (1.8 -2.5) min, while the duration of the subsequent ones increased to 1.7 (1.6 -1.9) min. Compared with MI -MII 24 h, the amplitude of the subsequent calcium transients in MI -MII 24 h V/W increased to 1.5 (0.9 -1.7) AU, whereas the frequency decreased to 1.2 (0.9 -1.4) calcium transients/h. In vitro aged V/W oocytes exhibited calcium transients of significantly longer duration of 1.9 (1.5-2.1) min, the calcium oscillations lasted for a shorter period of 4.7 (3-8.1) h and the total amount of calcium released decreased to 5.8 (5.0 -7.0) AU × min compared with in vitro aged oocytes (Fig. 2E) . The calcium oscillation pattern of frozen/ thawed in vitro matured and in vitro aged human oocytes
Slow freezing/thawing influenced the calcium oscillation pattern of in vitro matured and in vitro aged oocyte groups differently (Table II) . GV -MII 24 h F/T exhibited calcium oscillations at a significantly lower frequency of 1.2 (0.9-1.5) h each lasting for 1.5 (1.4 -1.8) min (Fig. 3A) . The MI -MII 3 h F/T group showed calcium oscillations of significantly higher amplitude compared with MI -MII 3 h: 1.6 (1.2 -2) AU for the first transient and 0.7 (0.6 -1) AU for the subsequent ones (Fig. 3B) . On the contrary, compared with their fresh counterparts, MI -MII 24 h F/T oocytes showed transients that were of significantly shorter duration of 2.5 (2.5 -3) min, of lower amplitude of 1.1 (1-1.7) AU, with a lower frequency of 0.9 (0.8-1.5) calcium transients/h and a lower amount of total calcium released of 3.6 (2.3 -6.6) AU × min. In vitro aged F/T oocytes exhibited calcium transients of significantly longer duration of 4 (3.5 -4) and 2.3 (1.7 -2.4) min for the first and the subsequent calcium transients, respectively, compared with in vitro aged oocytes. Calcium oscillations in human fertilized oocytes
Discussion
Calcium oscillations are both necessary and sufficient for oocyte activation and further embryonic development, though the full extent of their effect is only partially understood (Kline and Kline, 1992; Jones et al., 2004; Marangos and Carroll, 2004) . Nevertheless, the analysis of calcium oscillations can be utilized to evaluate the efficiency of in vitro culture and cryopreservation techniques. Calcium responses at fertilization are considered crucial for diagnosing cellular damage and evaluating cytoplasmic maturation Kim et al., 2011) . To our knowledge, these are the first data on how the calcium oscillation pattern in human MII oocytes is affected by the processes of V/W, slow freezing/thawing, in vitro maturation and in vitro ageing. The inherent variability in human oocyte quality may potentially confound the interpretation of comparative studies. To broadly make up for this, an adequately large number of oocytes coming from different patients was randomly allocated to the various experimental groups. In addition, the use of the same sperm donor for all experiments allowed us to minimize the effect of sperm variation on the calcium oscillation pattern. We show that human in vivo MII oocytes display a specific pattern of low-frequency calcium oscillations that cease within 5 h. This is consistent with the time course of male and female pronucleus formation after ICSI (Payne et al., 1997; Mio and Maeda, 2008) . The pattern of calcium oscillations is significantly affected by in vitro ageing, with calcium oscillations occurring over a longer period of time with a lower frequency, shorter duration and higher amplitude. In contrast, it has been shown in the mouse that the frequency is higher and the amplitude is lower in aged compared with fresh oocytes (Igarashi et al., 1997) . Sustained calcium oscillations in fertilized oocytes depend on the properties of the IP 3 R1, which is activated by low cytosolic calcium concentration while inhibited by higher levels. The particular pattern of calcium oscillations might also be determined by calcium-dependent IP 3 production, since PLCz is calcium sensitive (Nomikos et al., 2005; Swann and Yu, 2008) .
Despite the ingrained oocyte-to-oocyte variability in calcium responses, our results provide strong evidence for the notion that the precise source of human oocytes (fresh versus in vitro aged and in vivo versus in vitro matured) influences the pattern of calcium oscillations following ICSI. Direct comparison of the values of the calcium oscillation parameters with previous reports is not feasible because only collective results have been reported for failed fertilized (in vitro aged), in vivo MII and in vitro matured human oocytes (Tesarik et al., 1994; Yanagida et al., 2001 ). In the study by Tesarik et al. (1994) , the calcium oscillations initiated 2-12 h after ICSI, and occurred every 1-5 min in in vivo MII and failed fertilized human oocytes. Each calcium transient lasted for 20 s and the calcium oscillations continued for 0.5-1 h in total. In the study by Yanagida et al. (2001) , calcium measurement occurred for 3 h, calcium oscillations initiated 18.4 + 3.8 min after ICSI and calcium transients were seen on average every 11 min. In another study, IVF was employed with in vivo MII and failed fertilized human oocytes and calcium analysis was performed for 4 h. Calcium oscillations started 20-35 min later, occurred every 10 -35 min and lasted for 2 min each (Taylor et al., 1993) . It is evident from the aforementioned studies that the calcium responses of human oocytes are not only influenced by the variability between the oocytes and the sperm used, but also emanate from differences in the exact experimental setting. This also includes the choice of the calcium indicator used. The hydrolyzed forms of acetoxymethyl ester calcium indicators for instance can diffuse over time during the long calcium measurements inside organelles and vesicles and this might account for the trend of the resting calcium concentration of the oocytes to increase overtime (Takeuchi et al., 1989; Carroll et al., 1994; Swann, 2013) . Alternative fluorescent dyes, such as Dextran Fura-2, which are retained better in the cytosol might alleviate this problem (Swann, 2013) . Human oocytes obtained from stimulated cycles that failed to mature in vivo can be utilized in a research context or even clinically to maximize the reproductive outcome in cases where very few in vivo MII oocytes are collected (Vanhoutte et al., 2005; Escrich et al., 2011; Versieren et al., 2011; Zhang et al., 2011; Fasano et al., 2012; Shin et al., 2013) . However, the fertilization and cleavage rate of MI -MII oocytes that matured within 4 h after denudation is lower compared with in vivo MII oocytes (Strassburger et al., 2004; Shin et al., 2013) . On the contrary, other studies have shown that the fertilization rate of in vitro matured denuded oocytes from stimulated cycles is comparable to that of their sibling in vivo matured oocytes but embryo quality is reduced (Reichman et al., 2010) . The reduced developmental competence of in vitro matured oocytes might be due to several reasons. For example, in vitro matured human oocytes exhibit a higher incidence of abnormal spindle structures and disturbed chromosome configurations compared with in vivo matured oocytes (Li et al., 2006) . In addition, our study shows that in vitro maturation from the GV and MI stage changes the pattern of calcium oscillations with calcium transients being of shorter duration and lower frequency. When MI stage oocytes reach the MII stage within 3 h, calcium oscillations additionally occurred over a longer period of time, whereas when MI oocytes reach the MII stage within 24 h the calcium transients were additionally of higher amplitude. The observation that the shorter calcium transients of lower frequency are accompanied by either a higher total duration (MI-MII 3 h) or higher amplitude (MI -MII 24 h) could possibly explain the fact that they do sometimes lead to pregnancies when utilized clinically (Vanhoutte et al., 2005; Á lvarez et al., 2013) .
A common effect of in vitro culture of the in vitro matured and in vitro aged oocyte groups was the decrease in the frequency of the calcium oscillations and the duration of each calcium transient. However, other parameters of the calcium oscillations were influenced differently between these groups, which supports the idea that the maturation stage at which in vitro culture commenced is the main contributing factor. The in vitro matured oocyte groups were placed in culture either at the GV or MI stage and completed maturation in vitro, whereas the in vitro aged oocytes were placed in culture at the MII stage. The effect of different culture media on the calcium responses after fertilization is unknown.
In vivo MII oocytes show a different calcium oscillation pattern following V/W with transients occurring over a longer period of time, with a higher amplitude and a lower frequency. Our results are in contrast with Kim et al. (2011) , who showed that vitrification using ethylene glycol and DMSO does not significantly affect the calcium oscillation pattern of mouse oocytes after ICSI. This discrepancy highlights the fact that although animal studies can provide important insights, they are not always reliably informative for humans. Despite the differences in the calcium oscillation pattern, in vivo MII V/W oocytes obtained from donor cycles are not considered inferior to fresh in vivo MII oocytes in terms of ongoing pregnancy rates (Cobo et al., 2010) . Although vitrification of oocytes is superior to slow freezing with respect to survival rate and later embryological end-points (Saragusty and Arav, 2011) , fertilization and embryo transfer rates are still lower compared with fresh cycles (Magli et al., 2010) . Possibly, the lower frequency of calcium oscillations is sufficiently compensated by their higher amplitude and longer total duration, which is reflected by the increased amount of calcium released. This would be in agreement with previous work, which suggests that mouse oocyte activation is tolerant to calcium oscillation pattern perturbations as long as the total amount of calcium release is uncompromised and reaches a critical threshold (Ozil et al., 2005; Tóth et al., 2006) . Further, calcium signalling seems to influence not only oocyte activation events but also long-term postimplantation development (Ozil and Huneau, 2001; Ozil et al., 2006) .
In vitro matured oocytes from the GV or MI stage also display an altered pattern of calcium oscillations after V/W. Similarly, affected parameters in these oocyte groups were the frequency and the amplitude of the calcium transients. MI -MII 3 h V/W oocytes additionally had a significantly shorter first calcium transient and longer subsequent ones. This might explain the lower blastocyst formation rate of MI -MII 3 h V/W compared with in vivo MII V/W, which was reported previously (Chang et al., 2008) .
Slow freezing/thawing differentially affected the calcium oscillation pattern of in vitro matured and in vitro aged oocytes, which probably reflects differences in their susceptibility to the cryopreservation process. The different effects of V/W and slow freezing/thawing on the calcium response may explain at least in part why vitrification of in vivo and in vitro matured oocytes leads to higher fertilization rates when compared with slow freezing (Cao et al., 2009; Smith et al., 2010; Virant-Klun et al., 2011; Zhang et al., 2011) . The use of very high cooling rates in combination with a high concentration of cryoprotectants in vitrification protocols does not allow ice crystal formation (Vajta and Kuwayama, 2006) . However, this is not always possible during slow freezing protocols, leaving oocytes thus more vulnerable to cellular damage. Clinical studies have shown that slow freezing as opposed to vitrification has a more deleterious effect on the biological functions of the oocyte (Gook and Edgar, 2007) , probably due to cellular alterations instigated by osmotic forces during the dehydration-rehydration steps (Gualtieri et al., 2011) . The fact that all of the in vitro matured and in vitro aged oocyte groups (GV-MII 24 h, MI -MII 3 h, MI -MII 24 h and in vitro aged) showed a distinct influence of the slow freezing/thawing on the exhibited calcium oscillation pattern probably reflects differences in their plasma membrane permeability. This appears to be dependent not only on the duration of in vitro culture but also on the initial stage of the oocyte prior to their culture.
Despite the improved cryopreservation protocols, maturation and developmental deficiencies of human oocytes after cryopreservation have been reported, which may be related to disturbances of cell structures, such as the meiotic spindle, mitochondria, cortical granules, cytoskeleton and the calcium signalling machinery (Son et al., 1996; Boiso et . Vitrification has been shown to reduce and damage the cortical granules and smooth ER (SER) (Schalkoff et al., 1989; Shahedi et al., 2012) . Furthermore, alterations of mitochondria-SER aggregates may lead to disturbances in calcium signalling (Dumollard et al., 2006; Vajta and Nagy, 2006; Nottola et al., 2009; Khalili et al., 2012) and the formation of wide SER-derived vesicles can cause membrane rupture leading to calcium leakage (Bonetti et al., 2011) . Furthermore, slow freezing induces an irreversible loss of high mitochondrial polarity in human oocytes (Jones et al., 2004) . Moreover, a decrease in the calcium response after exposure to the calcium ionophore A23187 has been reported in oocytes after both slow freezing and vitrification (Jones et al., 2004; Gualtieri et al., 2011) . Exposure of mouse oocytes to commonly used cryoprotectants, such as 1,2-propanediol, ethylene glycol and DMSO, induces an immediate increase in intracellular calcium (Larman et al., 2006; . The effect of DMSO was apparent even in the absence of extracellular calcium, indicating that DMSO directly affects internal calcium stores (Larman et al., 2006; Gardner et al., 2007) . Exposure of human oocytes to 1,2-propanediol also causes a drastic decrease in cortical granules, which seems to imply that at least some degree of calcium rise has already been induced during the cryopreservation process (Ghetler et al., 2006) . The calcium release due to the cryoprotectants has therefore the potential to initiate oocyte activation, which could help to explain the inferior embryonic development after oocyte cryopreservation . A recent study has also provided evidence that calcium oscillations induce calcium influx into mouse oocytes, which is required to activate the downstream signalling molecules necessary for meiosis resumption and embryonic development. Therefore, improved oocyte cryopreservation techniques need to prevent calcium influx from occurring prematurely (Miao et al., 2012) .
Whether a single calcium oscillation parameter, such as the frequency or the amplitude, can be predictive of the success of human embryonic development is at this point not clear. In animal models, oocyte activation and embryonic development are mainly influenced by the total number of calcium oscillations (Ozil, 1998; Ducibella et al., 2006) . In failed fertilized human oocytes, blastocyst formation rate is higher when three calcium transients are provoked instead of only one (Zhang et al., 1999) . Since the use of calcium-sensitive fluorescent dyes and the highintensity excitation light may impair development (Squirrell et al., 1999) , determining the correlation of a particular calcium oscillation pattern with further embryonic development of the same fertilized oocyte cannot be done with conventional techniques. However, shortperiod calcium measurement of human oocytes does not preclude subsequent assessment of embryonic development (Tesarik et al., 1994; Yanagida et al., 2001) . Recently, it was shown that the occurrence and frequency of calcium oscillations in mouse oocytes and failed fertilized human oocytes can also be determined in a non-invasive way using particle image velocimetry (PIV) to detect small cytoplasmic movements, which are synchronous with and depend on calcium oscillations (Ajduk et al., 2011; Swann et al., 2012) . In mouse oocytes, these movements can serve as a predictor of the developmental potential of the zygote (Ajduk et al., 2011) . In the near future, PIV could enable us to correlate calcium oscillation pattern analyses with human embryonic development.
In conclusion, our study shows that the analysis of calcium oscillations, known for their critical role in oocyte activation, can be used as an indicator of cryodamage in human oocytes and can furthermore provide important insights into the underlying causes of failed fertilization. In addition, it emphasizes the need for further work directed towards improving human oocyte cryopreservation techniques.
